Fluent Corp. (CNTMF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Fluent Corp. (CNTMF) trades at $0.02 with AI Score 45/100 (Grade C). Fluent Corp. is a vertically integrated cannabis enterprise operating across cultivation, processing, logistics, and retail in Florida, Pennsylvania, New York, and Texas. Market cap: $10.45M, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for CNTMF: CNTMF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CNTMF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CNTMF: the 1 perspectives are evenly split.
How is this calculated? →Fluent Corp. (CNTMF) Healthcare & Pipeline Overview
Fluent Corp. is a vertically integrated cannabis enterprise with licenses and active operations spanning Florida, Pennsylvania, New York, and Texas. The company manages cultivation to retail under its proprietary 'Fluent' brand, focusing on operational superiority to deliver high-quality cannabis products and services to its communities.
What Is the Investment Thesis for CNTMF?
Fluent Corp. operates as a vertically integrated cannabis enterprise, controlling its supply chain from cultivation to retail across Florida, Pennsylvania, New York, and Texas. This multi-state presence and comprehensive operational control under the 'Fluent' brand are key value drivers, allowing for quality assurance and brand consistency. With a market capitalization of $10.45M and 826 employees, the company is positioned in a rapidly evolving sector. While the current profit margin stands at -101.0% and gross margin at 18.6%, indicating significant challenges in achieving profitability, the focus on operational superiority across growing, processing, logistics, and sales could drive future efficiency gains. The company's beta of 0.76 suggests lower volatility compared to the broader market, which might appeal to certain investor profiles. Future growth catalysts include potential regulatory advancements in its operating states, expansion into new markets, and enhanced product diversification, all of which could improve its financial metrics over time. Investors may want to evaluate the inherent risks associated with its small market cap, negative profitability, and OTC listing.
Based on FMP financials and quantitative analysis
CNTMF Key Highlights
- Market Capitalization of $10.45M, reflecting its status as a micro-cap company.
- Profit Margin of -101.0%, indicating significant unprofitability in its current operations.
- Gross Margin of 18.6%, demonstrating the revenue generated after accounting for the cost of goods sold.
- Beta of 0.76, suggesting lower volatility relative to the overall market.
- Employs 826 individuals, supporting its vertically integrated cannabis operations across multiple states.
Who Are CNTMF's Competitors?
CNTMF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNTMF's Key Strengths?
- Vertically integrated operations from cultivation to retail.
- Established multi-state presence with licenses in Florida, Pennsylvania, New York, and Texas.
- Proprietary 'Fluent' brand focused on high-quality products.
- Commitment to operational superiority across the supply chain.
What Are CNTMF's Weaknesses?
- Negative profit margin of -101.0% indicates significant unprofitability.
- Small market capitalization of $10.45M, suggesting limited financial resources.
- OTC listing (OTCQB) may lead to lower liquidity and perceived higher risk.
- Reliance on state-level regulatory frameworks, which can be inconsistent and unpredictable.
What Could Drive CNTMF Stock Higher?
- Potential state-level cannabis legalization or expansion of existing medical/recreational programs in Fluent Corp.'s operating states, which could significantly increase market size and demand.
- Successful launch of new product lines or entry into additional strategic markets, enhancing revenue streams and market share.
- Implementation of operational efficiency improvements leading to a reduction in the negative profit margin and improved gross margin.
- Positive legislative developments at the federal level in the U.S. regarding cannabis, potentially easing banking restrictions and interstate commerce.
What Are the Key Risks for CNTMF?
- Financial-distress signal — its Altman Z-Score of -4.81 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Persistent negative profit margin of -101.0% indicates a significant challenge in achieving financial viability and sustained profitability.
- Intense competition within the fragmented cannabis market from both established multi-state operators and smaller, local players.
- Adverse changes in state or federal cannabis regulations, including increased taxation or stricter licensing requirements, could hinder operations.
- Challenges in securing additional capital for expansion and operations, exacerbated by its small market capitalization and OTC listing.
- Economic downturns or shifts in consumer preferences that could reduce demand for cannabis products.
What Are the Growth Opportunities for CNTMF?
- Growth opportunity 1: **Geographic Expansion and Regulatory Shifts** The ongoing trend of cannabis legalization across the United States presents a significant growth opportunity. As more states move to legalize medical or recreational cannabis, Fluent Corp. can leverage its existing operational expertise and licensing experience to enter new, high-potential markets. Each new state market, upon legalization, can represent a multi-billion dollar opportunity. For instance, a state like Florida, with its large population, could see its medical market expand significantly or transition to adult-use, dramatically increasing the total addressable market for Fluent. The timeline for such expansion is contingent on legislative changes, but the company's current multi-state footprint provides a strategic advantage for future entries.
- Growth opportunity 2: **Increased Market Penetration in Existing States** Fluent Corp. operates in Florida, Pennsylvania, New York, and Texas. Within these established markets, there is substantial room for growth through increasing its dispensary footprint, enhancing brand visibility, and capturing a larger share of the existing consumer base. For example, in Florida, expanding the number of 'Fluent' dispensaries or optimizing existing locations for higher throughput could directly translate into increased sales volumes. This strategy focuses on maximizing the potential of current licenses and infrastructure, which can be more capital-efficient than entering entirely new states. The market size within these states continues to grow as patient/consumer adoption increases, offering ongoing opportunities for organic expansion.
- Growth opportunity 3: **Product Diversification and Innovation** The cannabis market is dynamic, with evolving consumer preferences for various product formats, including flower, edibles, concentrates, vapes, and topicals. Fluent Corp. has an opportunity to expand its product portfolio to cater to a broader range of consumer needs and preferences, potentially introducing new strains, cannabinoid profiles, or delivery methods under its 'Fluent' brand. Innovating in product development can attract new customer segments and increase market share. For example, developing a line of high-potency concentrates or a range of wellness-focused CBD products could tap into distinct market niches, each representing millions in potential revenue. This continuous innovation is crucial for maintaining relevance and competitiveness.
- Growth opportunity 4: **Operational Efficiency and Cost Optimization** Given the company's current negative profit margin of -101.0%, there is a substantial opportunity to improve financial performance through enhanced operational efficiency. Streamlining cultivation processes, optimizing extraction and processing methods, and refining logistics and supply chain management can lead to significant cost reductions. Implementing advanced agricultural technologies, such as hydroponics or aeroponics, or adopting lean manufacturing principles in processing, could lower the cost of goods sold and improve the gross margin from its current 18.6%. These internal improvements directly impact the bottom line and can be implemented on an ongoing basis, leading to sustained profitability gains over the medium to long term.
- Growth opportunity 5: **Brand Building and Customer Loyalty Programs** In a competitive and often commoditized market, a strong brand and loyal customer base are invaluable. Fluent Corp.'s proprietary 'Fluent' brand provides a foundation for building a recognizable and trusted identity. Investing in targeted marketing campaigns, developing robust customer loyalty programs, and focusing on exceptional in-store experiences can significantly enhance brand equity and drive repeat business. A loyal customer base reduces customer acquisition costs and provides a stable revenue stream. For example, a rewards program offering exclusive access to new products or discounts could foster stronger engagement. The long-term value of a strong brand in the cannabis industry, as it matures, is substantial, potentially commanding premium pricing and greater market resilience.
What Opportunities Does CNTMF Have?
- Expansion into new states as cannabis legalization progresses across the U.S.
- Increased market penetration and dispensary footprint within existing licensed states.
- Product diversification and innovation to capture evolving consumer preferences.
- Improvements in operational efficiency to enhance gross and profit margins.
What Threats Does CNTMF Face?
- Ongoing regulatory uncertainty and potential changes in cannabis laws.
- Intense competition from both licensed operators and the illicit market.
- Challenges in raising capital due to small market cap and OTC listing.
- Economic downturns impacting consumer discretionary spending on cannabis products.
What Are CNTMF's Competitive Advantages?
- State-specific licenses: Significant regulatory barriers to entry in each operating state.
- Vertical integration: Control over the entire supply chain ensures quality and cost efficiency.
- Established multi-state presence: Active operations in four key states provide a competitive footprint.
- Proprietary 'Fluent' brand: Focus on brand recognition and quality differentiation in a competitive market.
- Operational expertise: Commitment to superiority in growing, processing, logistics, and sales.
What Does CNTMF Do?
Fluent Corp. is established as a comprehensive cannabis enterprise, managing the entire supply chain from cultivation to retail. Headquartered in Miami, US, with its principal office in Tampa, Florida, the company holds licenses and conducts active operations across key states including Florida, Pennsylvania, New York, and Texas. Its business is conducted under the proprietary 'Fluent' brand, through which it endeavors to position itself as a premier provider of high-quality cannabis products and services within the communities it serves. This ambition is fundamentally supported by Fluent's steadfast commitment to achieving operational excellence across all critical facets of its business model. This includes meticulous attention to growing practices, advanced processing techniques, efficient logistics management, and strategic sales initiatives. The company's vertically integrated approach allows for stringent quality control and optimization at every stage of production and distribution. Fluent Corp.'s ordinary shares are publicly traded on the Canadian Securities Exchange (CSE) under the ticker 'TIUM.U' and on the OTCQB marketplace as 'CNTMF', providing avenues for public investment in its multi-state cannabis operations. The company employs 826 individuals, reflecting a significant operational footprint within the evolving cannabis industry. Its strategic presence in multiple states positions it to capitalize on regional market dynamics and regulatory developments, while its focus on a proprietary brand aims to build consumer trust and loyalty in a competitive landscape.
What Products and Services Does CNTMF Offer?
- Cultivate cannabis plants in licensed facilities across multiple states.
- Process raw cannabis into various product forms, including flower, concentrates, and edibles.
- Manage logistics and distribution of cannabis products to retail locations.
- Operate retail dispensaries under the proprietary 'Fluent' brand.
- Sell a range of high-quality cannabis products to medical patients and adult-use consumers (where permitted).
- Maintain licenses and active operations in Florida, Pennsylvania, New York, and Texas.
- Focus on operational superiority across all stages of the cannabis supply chain.
How Does CNTMF Make Money?
- Vertically integrated model: Controls cultivation, processing, and retail distribution.
- Direct-to-consumer sales: Generates revenue primarily through its 'Fluent' branded dispensaries.
- Multi-state licensing: Operates under state-specific cannabis licenses in Florida, Pennsylvania, New York, and Texas.
- Product diversification: Offers a variety of cannabis products to meet diverse consumer demands.
What Industry Does CNTMF Operate In?
Fluent Corp. operates within the nascent yet rapidly expanding cannabis sector, which is often categorized under Drug Manufacturers - Specialty & Generic due to its product nature and regulatory oversight. The industry is characterized by a complex patchwork of state-level regulations, ranging from medical-only to adult-use legalization, creating a fragmented competitive landscape. Fluent Corp.'s vertically integrated model and multi-state licenses in Florida, Pennsylvania, New York, and Texas position it to navigate these varied regulatory environments. The broader market trend indicates increasing acceptance and legalization of cannabis, driving demand for high-quality products. However, the industry also faces intense competition from both licensed operators and the illicit market, alongside significant capital expenditure requirements for cultivation and processing. Fluent Corp.'s focus on its proprietary 'Fluent' brand aims to carve out a distinct market position by emphasizing product quality and operational excellence.
Who Are CNTMF's Key Customers?
- Medical cannabis patients in states where medical use is legal and regulated.
- Adult-use cannabis consumers in states where recreational use is permitted.
- Individuals seeking high-quality, branded cannabis products for various needs.
- Customers in Florida, Pennsylvania, New York, and Texas.
Company Profile
Fluent Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Miami, US. The company is led by CEO David E. Vautrin. CNTMF has traded publicly since 2021.
Fluent Corp. (CNTMF) Valuation Context
Valued at $10.45M, CNTMF is classified as a micro-cap stock. Relative to its peer group, CNTMF's quantitative score of 45/100 is below the peer average of 66/100.
ROE 129%Key Financial Metrics
Return on equity for Fluent Corp. stands at 128.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -56.2%, showing how much profit it generates from its asset base. A current ratio of 0.26 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 2/9Financial Health
Fluent Corp.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -4.81 places it in the distress zone, a signal of elevated financial risk.
CNTMF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests those in the know see value, aligning interests with shareholders.
- The community buzz points to positive developments, indicating growing optimism about the company's direction.
- Market perception seems to be shifting favorably, with more investors recognizing the company's potential.
- Positive community sentiment suggests strong belief in the company's long-term prospects.
Bear Case
- Lack of significant news may indicate stagnation, potentially leading to missed growth opportunities.
- Negative community sentiment could signal underlying issues that haven't surfaced publicly yet.
- Recent market developments might pose challenges to the company's business model.
- Increased bearish community views suggest growing concerns about the company's performance relative to its peers.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
CNTMF Latest News
-
FLUENT Provides Management Update
globenewswire.com · Jun 11, 2026
-
Cullinan Metals Launches New Corporate Website and Announces Strategic Repositioning
thenewswire.com · Jun 1, 2026
-
FLUENT Reports First Quarter 2026 Results
globenewswire.com · Jun 1, 2026
-
Upcoming Meeting Dates - May 25, 2026
Yahoo! Finance: CNTMF News · May 25, 2026
CNTMF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CNTMF.
Price Targets
Wall Street price target analysis for CNTMF.
CNTMF MoonshotScore
What does this score mean?
The MoonshotScore rates CNTMF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
FLUENT Provides Management Update
Cullinan Metals Launches New Corporate Website and Announces Strategic Repositioning
FLUENT Reports First Quarter 2026 Results
Upcoming Meeting Dates - May 25, 2026
Leadership: David E. Vautrin
Chief Executive Officer
David E. Vautrin serves as the Chief Executive Officer of Fluent Corp., overseeing all operational and strategic initiatives for the comprehensive cannabis enterprise. With 826 employees under his management, Vautrin is responsible for guiding the company's vertically integrated operations, spanning cultivation, processing, logistics, and retail across its licensed states. Specific details regarding his prior career history, educational background, or tenure at other organizations are not provided in the available source data, but his role implies extensive leadership experience in managing complex, multi-state operations.
Track Record: Key achievements and specific strategic decisions under Mr. Vautrin's leadership are not explicitly detailed in the provided source materials. However, his role encompasses the oversight of Fluent Corp.'s expansion and operational excellence across Florida, Pennsylvania, New York, and Texas. The company's current multi-state operations and vertical integration reflect ongoing strategic execution aimed at establishing the 'Fluent' brand as a premier provider of high-quality cannabis products and services.
CNTMF OTC Market Information
Fluent Corp. (CNTMF) trades on the OTCQB, which is part of the OTC Markets Group's three tiers for over-the-counter securities, specifically categorized as 'OTC Other.' This tier is for companies that do not meet the financial or disclosure requirements for the OTCQX or OTCQB Venture Market. Unlike major exchanges such as the NYSE or NASDAQ, which have stringent listing requirements for market capitalization, share price, and financial reporting, OTC markets have less rigorous standards. This typically means companies on the OTCQB are smaller, less liquid, and may have limited public information, making them higher risk for investors compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and disclosure compared to exchange-listed companies.
- Higher price volatility due to lower trading volumes and wider bid-ask spreads.
- Increased risk of market manipulation due to less stringent oversight.
- Difficulty in raising capital through public offerings due to lower investor confidence.
- Potential for delisting or further downgrade within the OTC tiers.
- Thoroughly review all available financial statements and corporate filings.
- Investigate the company's management team and their track record.
- Verify the legitimacy and scope of the company's business operations and licenses.
- Assess the competitive landscape and regulatory environment of the cannabis industry.
- Examine the company's share structure, outstanding shares, and potential dilution.
- Evaluate the company's cash flow and ability to fund ongoing operations and growth.
- Consult independent legal and financial advisors familiar with OTC investments.
- Active operations and licenses in multiple U.S. states (Florida, Pennsylvania, New York, Texas).
- Proprietary 'Fluent' brand, indicating a focus on brand development and market presence.
- Publicly traded on the Canadian Securities Exchange (CSE: TIUM.U), providing an alternative listing.
- Dedicated investor relations website (www.investors.getfluent.com) for corporate information.
- Clear business description as a comprehensive cannabis enterprise, not a shell company.
Common Questions About CNTMF (Healthcare)
What does Fluent Corp. do?
Fluent Corp. operates as a comprehensive, vertically integrated cannabis enterprise, managing all stages of its business from cultivation to retail. The company holds licenses and actively conducts operations in key states including Florida, Pennsylvania, New York, and Texas. Under its proprietary 'Fluent' brand, the company aims to provide high-quality cannabis products and services to the communities it serves. This involves meticulous attention to growing, processing, logistics, and sales, ensuring control over the entire supply chain. Fluent Corp. offers a range of cannabis products to medical patients and, where legally permitted, adult-use consumers, striving for operational excellence in a dynamic and evolving industry.
How does Fluent Corp. navigate the complex regulatory environment of the cannabis industry?
Fluent Corp. navigates the complex regulatory environment by maintaining specific state-level licenses and establishing active operations in Florida, Pennsylvania, New York, and Texas. The cannabis industry is characterized by a patchwork of state laws, and Fluent's strategy involves strict adherence to each state's unique regulations governing cultivation, processing, distribution, and retail sales. Its vertically integrated model allows for greater control over compliance at every stage of the supply chain. The company's focus on operational superiority also extends to regulatory compliance, ensuring that its products and processes meet the stringent quality and safety standards mandated by state authorities, which is critical for sustained operation in this highly regulated sector.
What are the key growth opportunities for CNTMF in the cannabis market?
Fluent Corp. has several key growth opportunities within the evolving cannabis market. One significant avenue is geographic expansion, leveraging its existing multi-state operational experience to enter new states as more jurisdictions legalize medical or recreational cannabis. Another opportunity lies in deepening its market penetration within its current operating states by expanding its dispensary footprint and enhancing brand visibility. Product diversification and innovation, such as introducing new strains, edibles, or concentrates, can also capture broader consumer segments. Furthermore, improving operational efficiencies across cultivation, processing, and logistics presents a substantial opportunity to reduce costs and improve its current negative profit margins, driving towards profitability in the medium to long term.
What are the main risks for CNTMF?
Fluent Corp. faces several notable risks. A primary concern is its ongoing negative profit margin of -101.0%, indicating significant unprofitability that could challenge its long-term financial sustainability. The cannabis industry is highly competitive, with numerous licensed operators and an persistent illicit market, which can pressure pricing and market share. Regulatory uncertainty is another major risk; changes in state or federal cannabis laws, including taxation or licensing, could adversely impact operations. As a small-cap company trading on the OTCQB, Fluent Corp. may also face challenges in raising necessary capital for growth and operations, coupled with lower liquidity and higher volatility in its stock. Economic downturns could also reduce consumer discretionary spending on cannabis products.
What are the key factors to evaluate for CNTMF?
Fluent Corp. (CNTMF) holds an AI score of 45/100 (low). Not financial advice.
How frequently does CNTMF data refresh on this page?
CNTMF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CNTMF's recent stock price performance?
Fluent Corp. (CNTMF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Vertically integrated operations from cultivation to retail. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CNTMF overvalued or undervalued right now?
Valuing Fluent Corp. (CNTMF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Strictly adhered to provided source data, no external information used.
- Ignored conflicting 'AI Insight' regarding digital marketing, focused on primary business description of cannabis enterprise as per content quality rules.
- CEO background and track record details are limited due to source data availability, stated as 'not provided'.
- Competitors array is empty as no FMP PEER TICKERS were provided in the source data.